Compared to Estimates, HCA (HCA) Q3 Earnings: A Look at Key Metrics

Core Insights - HCA Healthcare reported a revenue of $19.16 billion for the quarter ended September 2025, reflecting a year-over-year increase of 9.6% [1] - The earnings per share (EPS) for the quarter was $6.96, up from $5.05 in the same quarter last year, indicating a significant growth [1] - The reported revenue exceeded the Zacks Consensus Estimate of $18.5 billion by 3.55%, and the EPS surpassed the consensus estimate of $5.65 by 23.19% [1] Financial Performance Metrics - Revenue per Equivalent Admission was $18,446, exceeding the average estimate of $17,966.71 [4] - Equivalent Admissions reached 1.04 billion, slightly above the estimated 1.03 billion [4] - Total Admissions were reported at 577.8 million, compared to the estimated 575.37 million [4] - Patient Days totaled 2,692.51, which was below the average estimate of 2,718.89 [4] - The Average Length of Stay remained consistent at 5 days, matching the estimate [4] - The number of hospitals remained stable at 191, in line with estimates [4] - Inpatient Revenue per Admission was $19,908, surpassing the average estimate of $19,196.22 [4] - Equivalent Patient Days were reported at 4.84 million, slightly below the average estimate of 4.86 million [4] - Licensed Beds at the end of the period were 50,577, exceeding the average estimate of 50,346 [4] - The number of freestanding outpatient surgery centers was 123, slightly below the average estimate of 124 [4] Stock Performance - HCA shares have returned +6.1% over the past month, outperforming the Zacks S&P 500 composite's +1.3% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]